Azelis
Short position disclosed on September 16, 2026.
0.69% of the capital sold short
1 disclosing fund
3 disclosures on record
BE0974400328 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Aug 8Aug 18Aug 28Sep 7Sep 17
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Capital Fund Management | 0.69% | +0.08 pt | September 16, 2026 |
In the United States AZLGF (OTC): 235,095 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Azelis Titelia
Get the moves on Azelis by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 16, 2026 | Capital Fund Management | 0.69% | still open |
| August 11, 2026 | Capital Fund Management | 0.71% | |
| July 29, 2026 | Capital Fund Management | 0.61% |
Download 3 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 1.39% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Umicore 1.20% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- EVS 0.89% of the capital sold short
- D'Ieteren Group 0.79% of the capital sold short
- Syensqo 0.79% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Montea 0.60% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Azelis, source FSMA, data as at September 16, 2026, https://www.quivad.com/action/azelis